It regulates IGF signaling and apoptosis via IGF-independent mechanisms, potentially influencing endothelial dysfunction and vascular remodeling in PAH. and Its role remains incompletely defined; future studies may clarify its biomarker and therapeutic relevance. The gene discussed is IGF1; the disease is pulmonary arterial hypertension.